Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing

Company Advances Beyond Public Cancer Imaging Datasets With First Real-World User-Submitted Testing Phase MESA, AZ / ACCESS Newswire / August...

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

error: Content is protected !!